Cheikh I. Seye

Cheikh I. Seye

Auto-generated profile, based on publicly available information

Cheikh I. Seye

Department of Cellular & Integrative Physiology, Indiana University School of Medicine 635 Barnhill Drive MS 332, Indianapolis, IN 46202

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
XCXingjuan Chen
Xingjuan Chen
SQShaomin Qian
Shaomin Qian
AHApril Hoggatt
April Hoggatt
HTHongying Tang
Hongying Tang
THTimothy A. Hacker
Timothy A. Hacker
CSCheikh I. Seye
Cheikh I. Seye
Objective—: Nucleotide P2Y 2 receptor (P2Y 2 R) contributes to vascular inflammation by increasing vascular cell adhesion molecule-1 expression in endothelial cells (EC), and global P2Y 2 R deficiency prevents fatty streak formation in apolipoprotein E null (ApoE −/− ) mice. Because P2Y 2 R is ubiquitously expressed in vascular cells, we investigated the contribution of endothelial P2Y 2 R in the pathogenesis of atherosclerosis. Approach and Results—: EC-specific P2Y 2 R-deficient mice were generated by breeding VEcadherin5-Cre mice with the P2Y 2 R floxed mice. Endothelial P2Y 2 R deficiency reduced endothelial nitric oxide synthase activity and significantly altered ATP- and UTP (uridine 5’-triphosphate)-induced vasorelaxation without affecting vasodilatory responses to acetylcholine. Telemetric blood pressure and echocardiography measurements indicated that EC-specific P2Y 2 R-deficient mice did not develop hypertension. We investigated the role of endothelial P2Y 2 R in the development of atherosclerotic lesions by crossing the EC-specific P2Y 2 R knockout mice onto an ApoE −/− background and evaluated lesion development after feeding a standard chow diet for 25 weeks. Histopathologic examination demonstrated reduced atherosclerotic lesions in the aortic sinus and entire aorta, decreased macrophage infiltration, and increased smooth muscle cell and collagen content, leading to the formation of a subendothelial fibrous cap in EC-specific P2Y 2 R-deficient ApoE −/− mice. Expression and proteolytic activity of matrix metalloproteinase-2 was significantly reduced in atherosclerotic lesions from EC-specific P2Y 2 R-deficient ApoE −/− mice. Furthermore, EC-specific P2Y 2 R deficiency inhibited nitric oxide production, leading to significant increase in smooth muscle cell migration out of aortic explants. Conclusions—: EC-specific P2Y 2 R deficiency reduces atherosclerotic burden and promotes plaque stability in ApoE −/− mice through impaired macrophage infiltration acting together with reduced matrix metalloproteinase-2 activity and increased smooth muscle cell migration.

15 December 2016 in Atherosclerosis
Verified
Journal Article
Open access
PDF file
SQShaomin Qian
Shaomin Qian
JRJenna N. Regan
Jenna N. Regan
MSMaxwell T. Shelton
Maxwell T. Shelton
AHApril Hoggatt
April Hoggatt
KMKhalid S. Mohammad
Khalid S. Mohammad
CSCheikh I. Seye
Cheikh I. Seye
Vascular calcification is a hallmark of many diseases including atherosclerosis, type 2 diabetes, end-stage renal disease, and is highly correlated with cardiovascular morbidity [ 1 x [1] Block, G.A. Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients. Clin. Nephrol. 2000; 54: 318–324 PubMed | Google Scholar See all References , 2 x [2] Zhu, D., Mackenzie, N.C.W., Farquharson, C. et al. Mechanisms and clinical consequences of vascular calcification. Front. Endocrinol. 2012; 3: 95 Crossref | PubMed | Scopus (42) | Google Scholar See all References ]. Arterial medial calcification occurs in the absence of inflammation, and is associated with chronic kidney disease (CDK) in adults [ 3 x [3] Shroff, R.C., McNair, R., Figg, N., Skepper, J.N., Schurgers, L., Gupta, A., Hiorns, M., Donald, A.E., Deanfield, J., Rees, L., and Shanahan, C.M. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation. 2008; 118: 1748–1757 Crossref | PubMed | Scopus (283) | Google Scholar See all References , 4 x [4] Goodman, W.G., London, G., Amann, K., Block, G.A., Giachelli, C., Hruska, K.A., Ketteler, M., Levin, A., Massy, Z., McCarron, D.A., Raggi, P., Shanahan, C.M., and Yorioka, N. Vascular calcification in chronic kidney disease. Am. J. kidney Dis. 2004; 43: 572–579 Abstract | Full Text | Full Text PDF | PubMed | Scopus (322) | Google Scholar See all References , 5 x [5] Moorthi, R.N. and Moe, S.M. CKD-mineral and bone disorder: core curriculum. Am. J. KidneyDis. 2011; 58: 1022–1036 Abstract | Full Text | Full Text PDF | PubMed | Scopus (38) | Google Scholar See all References ]. Medial calcification causes vessel stiffening, elevated pulse-wave velocity, and increased left ventricular (LV) load with hypertrophy [ 6 x [6] Guerin, A.P., Pannier, B., Metivier, F., Marchais, S.J., and London, G.M. Assessment and significance of arterial stiffness in patients with chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 2008; 17: 635–641 Crossref | PubMed | Scopus (75) | Google Scholar See all References , 7 x [7] London, G.M., Guerin, A.P., Marchais, S.J., Metivier, F., Pannier, B., and Adda, H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol. Dial. Transpl. 2003; 18: 1731–1740 Crossref | PubMed | Scopus (1235) | Google Scholar See all References , 8 x [8] Kelly, R.P., Tunin, R., and Kass, D.A. Effect of reduced aortic compliance on cardiac efficiency and contractile function of in situ canine left ventricle. Circ. Res. 1992; 71: 490–502 Crossref | PubMed | Scopus (240) | Google Scholar See all References , 9 x [9] Niederhoffer, N., Lartaud-Idjouadiene, I., Giummelly, P., Duvivier, C., Peslin, R., and Atkinson, J. Calcification of medial elastic fibers and aortic elasticity. Hypertension. 1997; 29: 999–1006 Crossref | PubMed | Scopus (135) | Google Scholar See all References ]. In contrast, intimal calcification occurs in the context of atherosclerosis and is associated with plaque rupture and myocardial infarction [ 10 x [10] Beadenkopf, W.G., Daoud, A.S., and Love, B.M. Calcification in the coronary arteries and its relationship to arteriosclerosis and myocardial infarction. Am. J. Roentgenol. Radium Ther. Nucl. Med. 1964; 92: 865–887 PubMed | Google Scholar See all References , 11 x [11] Kelly-Arnold, A., Maldonado, N., Laudier, D., Aikawa, E., Cardoso, L., and Weinbaum, S. Revised microcalcification hypothesis for fibrous cap rupture in human coronary arteries. Proc. Natl. Acad. Sci. 2013; 110: 10741–10746 Crossref | PubMed | Scopus (107) | Google Scholar See all References , 12 x [12] Ehara, S., Kobayashi, Y., Yoshiyama, M., Shimada, K., Shimada, Y., Fukuda, D., Nakamura, Y., Yamashita, H., Yamagishi, H., Takeuchi, K., Naruko, T., Haze, K., Becker, A.E., Yoshikawa, J., and Ueda, M. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation. 2004; 110: 3424–3429 Crossref | PubMed | Scopus (431) | Google Scholar See all References ]. Vascular calcification is an active and regulated process reminiscent of physiological bone formation [ 12 x [12] Ehara, S., Kobayashi, Y., Yoshiyama, M., Shimada, K., Shimada, Y., Fukuda, D., Nakamura, Y., Yamashita, H., Yamagishi, H., Takeuchi, K., Naruko, T., Haze, K., Becker, A.E., Yoshikawa, J., and Ueda, M. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation. 2004; 110: 3424–3429 Crossref | PubMed | Scopus (431) | Google Scholar See all References ] [12] . VSMC are the main cell type involved in arterial calcification, and can trans-differentiate into an osteoblast-like cell [ 13 x [13] Shroff, R.C., McNair, R., Figg, N. et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation. 2008; 118: 1748–1757 Crossref | PubMed | Scopus (225) | Google Scholar See all References , 14 x [14] Zhu, D., Mackenzie, N.C., Millan, J.L. et al. The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PloS ONE. 2011; 6: e19595 Crossref | PubMed | Scopus (143) | Google Scholar See all References ]. This phenotypic transition is characterized by the expression of alkaline phosphatase, type I collagen, osteocalcin and the formation of mineralized bone-like structures [ 15 x [15] Collin-Osdoby, P. Circ. Res. 2004; 95: 1046–1057 Crossref | PubMed | Scopus (335) | Google Scholar See all References ] [15] .

11 October 2016 in Journal of Vascular Research
Verified
Journal Article
Open access
PDF file
YAYuksel Agca
Yuksel Agca
SQShaomin Qian
Shaomin Qian
CACansu Agca
Cansu Agca
CSCheikh I. Seye
Cheikh I. Seye
Objectives: Extracellular nucleotide release at the site of arterial injury mediates the proliferation and migration of vascular smooth muscle cells. Our aim was to investigate the role of the P2Y2 nucleotide receptor (P2Y2R) in neointimal hyperplasia. Approach and Results: Vascular injury was induced by the implantation of a polyethylene cuff around the femoral artery in wild-type and P2Y2R-deficient mice (P2Y2R-/-). Electron microscopy was used to analyze monocyte and lymphocyte influx to the intima 36 h after injury. Compared to wild-type littermates, P2Y2R-/- mice exhibited a 3-fold decreased number of mononuclear leukocytes invading the intima (p < 0.05). Concomitantly, the migration of smooth muscle cells was decreased by more than 60% (p < 0.05), resulting in a sharp inhibition of intimal thickening formation in P2Y2R-/- mice (n = 15) 14 days after cuff placement. In vitro, loss of P2Y2R significantly impaired monocyte migration in response to nucleotide agonists. Furthermore, transgenic rats overexpressing the P2Y2R developed accelerated intimal lesions resulting in more than 95% luminal stenosis (p < 0.05, n = 10). Conclusions: Loss- and gain-of-function approaches established direct evidence for P2Y2R involvement in neointimal hyperplasia. Specific anti-P2Y2R therapies may be used against restenosis and bypass graft failure.

26 June 2016 in Vascular Pharmacology
Verified
Journal Article
Open access
SQShaomin Qian
Shaomin Qian
AHApril Hoggatt
April Hoggatt
YJYava L. Jones-Hall
Yava L. Jones-Hall
CWCarl F. Ware
Carl F. Ware
PHPaul Herring
Paul Herring
CSCheikh I. Seye
Cheikh I. Seye
Background: Lymphotoxin alpha (LTα) is expressed in human atherosclerotic lesions and genetic variations in the LTα pathway have been linked to myocardial infarction. Activation of the P2Y2 nucleotide receptor (P2Y2R) regulates the production of LTα. in vitro. We aimed to uncover a potential pathway linking purinergic receptor to LTα-mediated inflammatory processes pivotal to the early stages of atherosclerosis in apolipoprotein E (ApoE−/−) deficient mice. Methods and results En face immunostaining revealed that P2Y2R and VCAM-1 are preferentially expressed in the atherosclerosis prone site of the mouse aortic sinus. Deletion of the P2Y2R gene suppresses VCAM-1 expression. Compared with ApoE−/− mice, ApoE−/− mice lacking the P2Y2R gene (ApoE−/−/P2Y2R−/−) did not develop fatty streak lesions when fed a standard chow diet for 15 weeks. Systemic and CD4+ T cell production of the pro-inflammatory cytokine lymphotoxin-alpha (LTα) were specifically inhibited in ApoE−/−/P2Y2R−/−mice. Anti-LTα preventive treatment was initiated in ApoE−/− mice with intraperitoneal administration of recombinant human tumor necrosis factor receptor 1 fusion protein (TNFR1-Fc) on 5 consecutive days before the disease onset. Remarkably, none of the TNFR1:Fc-treated ApoE−/− mice exhibited atherosclerotic lesions at any developmental stage. Significance: ApoE−/− mice deficient in P2Y2R exhibit low endothelial cell VCAM-1 levels, decreased production of LTα and delayed onset of atherosclerosis. These data suggest that targeting this nucleotide receptor could be an effective therapeutic approach in atherosclerosis.